Yunnan Botanee Bio-Technology Group Co Ltd (300957) — Capital Reinvestment Ratio
Yunnan Botanee Bio-Technology Group Co Ltd (300957) has a Capital Reinvestment Ratio of 0.23x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥125.55 Million) in capital expenditures (CN¥29.13 Million). See 300957 equity financing ratio to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Yunnan Botanee Bio-Technology Group Co Ltd Capital Reinvestment Ratio (2017–2025)
This chart tracks Yunnan Botanee Bio-Technology Group Co Ltd's Capital Reinvestment Ratio across 9 annual periods. Check how aggressively does Yunnan Botanee Bio-Technology Group Co L reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Yunnan Botanee Bio-Technology Group Co Ltd (2017–2025)
Year-by-year Capital Reinvestment Ratio for Yunnan Botanee Bio-Technology Group Co Ltd from 2017 to 2025. For live market cap and broader valuation context, see 300957 market cap.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.49x | CN¥976.60 Million | CN¥482.99 Million | ▼ -9.2% |
| 2024 | 0.54x | CN¥694.87 Million | CN¥378.38 Million | ▲ +21.2% |
| 2023 | 0.45x | CN¥610.44 Million | CN¥274.28 Million | ▼ -2.2% |
| 2022 | 0.46x | CN¥769.45 Million | CN¥353.42 Million | ▲ +95.6% |
| 2021 | 0.23x | CN¥1.15 Billion | CN¥270.68 Million | ▲ +13.1% |
| 2020 | 0.21x | CN¥431.03 Million | CN¥89.45 Million | ▲ +75.2% |
| 2019 | 0.12x | CN¥514.92 Million | CN¥61.01 Million | ▼ -61.6% |
| 2018 | 0.31x | CN¥102.20 Million | CN¥31.56 Million | ▲ +359.1% |
| 2017 | 0.07x | CN¥202.44 Million | CN¥13.62 Million | — |